Login / Signup

Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms.

Pamela AchaMarisol XandriFrancisco Fuster-TormoLaura PalomoBlanca XicoyMarta CabezónSilvia MarcéIsabel GranadaDolors VelaMiguel SagüésConcepcion BoqueEsther PlensaAlberto PinedaEvarist FeliuFrancesc SoléLurdes Zamora
Published in: American journal of hematology (2019)
Keyphrases
  • cancer therapy
  • drug delivery